Global Recombinant Therapeutic Protein Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Recombinant Therapeutic Protein Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Recombinant Therapeutic Protein by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Recombinant Therapeutic Protein by Country/Region, 2017, 2022 & 2028

2.2 Recombinant Therapeutic Protein Segment by Type

2.2.1 Recombinant Human Collage

2.2.2 Recombinant Human Serum Albumin

2.3 Recombinant Therapeutic Protein Sales by Type

2.3.1 Global Recombinant Therapeutic Protein Sales Market Share by Type (2017-2022)

2.3.2 Global Recombinant Therapeutic Protein Revenue and Market Share by Type (2017-2022)

2.3.3 Global Recombinant Therapeutic Protein Sale Price by Type (2017-2022)

2.4 Recombinant Therapeutic Protein Segment by Application

2.4.1 Medicine

2.4.2 Scientific Research

2.4.3 Others

2.5 Recombinant Therapeutic Protein Sales by Application

2.5.1 Global Recombinant Therapeutic Protein Sale Market Share by Application (2017-2022)

2.5.2 Global Recombinant Therapeutic Protein Revenue and Market Share by Application (2017-2022)

2.5.3 Global Recombinant Therapeutic Protein Sale Price by Application (2017-2022)

3 Global Recombinant Therapeutic Protein by Company

3.1 Global Recombinant Therapeutic Protein Breakdown Data by Company

3.1.1 Global Recombinant Therapeutic Protein Annual Sales by Company (2020-2022)

3.1.2 Global Recombinant Therapeutic Protein Sales Market Share by Company (2020-2022)

3.2 Global Recombinant Therapeutic Protein Annual Revenue by Company (2020-2022)

3.2.1 Global Recombinant Therapeutic Protein Revenue by Company (2020-2022)

3.2.2 Global Recombinant Therapeutic Protein Revenue Market Share by Company (2020-2022)

3.3 Global Recombinant Therapeutic Protein Sale Price by Company

3.4 Key Manufacturers Recombinant Therapeutic Protein Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Recombinant Therapeutic Protein Product Location Distribution

3.4.2 Players Recombinant Therapeutic Protein Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Recombinant Therapeutic Protein by Geographic Region

4.1 World Historic Recombinant Therapeutic Protein Market Size by Geographic Region (2017-2022)

4.1.1 Global Recombinant Therapeutic Protein Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Recombinant Therapeutic Protein Annual Revenue by Geographic Region

4.2 World Historic Recombinant Therapeutic Protein Market Size by Country/Region (2017-2022)

4.2.1 Global Recombinant Therapeutic Protein Annual Sales by Country/Region (2017-2022)

4.2.2 Global Recombinant Therapeutic Protein Annual Revenue by Country/Region

4.3 Americas Recombinant Therapeutic Protein Sales Growth

4.4 APAC Recombinant Therapeutic Protein Sales Growth

4.5 Europe Recombinant Therapeutic Protein Sales Growth

4.6 Middle East & Africa Recombinant Therapeutic Protein Sales Growth

5 Americas

5.1 Americas Recombinant Therapeutic Protein Sales by Country

5.1.1 Americas Recombinant Therapeutic Protein Sales by Country (2017-2022)

5.1.2 Americas Recombinant Therapeutic Protein Revenue by Country (2017-2022)

5.2 Americas Recombinant Therapeutic Protein Sales by Type

5.3 Americas Recombinant Therapeutic Protein Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Recombinant Therapeutic Protein Sales by Region

6.1.1 APAC Recombinant Therapeutic Protein Sales by Region (2017-2022)

6.1.2 APAC Recombinant Therapeutic Protein Revenue by Region (2017-2022)

6.2 APAC Recombinant Therapeutic Protein Sales by Type

6.3 APAC Recombinant Therapeutic Protein Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Recombinant Therapeutic Protein by Country

7.1.1 Europe Recombinant Therapeutic Protein Sales by Country (2017-2022)

7.1.2 Europe Recombinant Therapeutic Protein Revenue by Country (2017-2022)

7.2 Europe Recombinant Therapeutic Protein Sales by Type

7.3 Europe Recombinant Therapeutic Protein Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Recombinant Therapeutic Protein by Country

8.1.1 Middle East & Africa Recombinant Therapeutic Protein Sales by Country (2017-2022)

8.1.2 Middle East & Africa Recombinant Therapeutic Protein Revenue by Country (2017-2022)

8.2 Middle East & Africa Recombinant Therapeutic Protein Sales by Type

8.3 Middle East & Africa Recombinant Therapeutic Protein Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Recombinant Therapeutic Protein

10.3 Manufacturing Process Analysis of Recombinant Therapeutic Protein

10.4 Industry Chain Structure of Recombinant Therapeutic Protein

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Recombinant Therapeutic Protein Distributors

11.3 Recombinant Therapeutic Protein Customer

12 World Forecast Review for Recombinant Therapeutic Protein by Geographic Region

12.1 Global Recombinant Therapeutic Protein Market Size Forecast by Region

12.1.1 Global Recombinant Therapeutic Protein Forecast by Region (2023-2028)

12.1.2 Global Recombinant Therapeutic Protein Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Recombinant Therapeutic Protein Forecast by Type

12.7 Global Recombinant Therapeutic Protein Forecast by Application

13 Key Players Analysis

13.1 Boehringer Ingelheim

13.1.1 Boehringer Ingelheim Company Information

13.1.2 Boehringer Ingelheim Recombinant Therapeutic Protein Product Offered

13.1.3 Boehringer Ingelheim Recombinant Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Boehringer Ingelheim Main Business Overview

13.1.5 Boehringer Ingelheim Latest Developments

13.2 Bristol-Myers Squibb

13.2.1 Bristol-Myers Squibb Company Information

13.2.2 Bristol-Myers Squibb Recombinant Therapeutic Protein Product Offered

13.2.3 Bristol-Myers Squibb Recombinant Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bristol-Myers Squibb Main Business Overview

13.2.5 Bristol-Myers Squibb Latest Developments

13.3 Celldex Therapeutics

13.3.1 Celldex Therapeutics Company Information

13.3.2 Celldex Therapeutics Recombinant Therapeutic Protein Product Offered

13.3.3 Celldex Therapeutics Recombinant Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Celldex Therapeutics Main Business Overview

13.3.5 Celldex Therapeutics Latest Developments

13.4 Eli Liily

13.4.1 Eli Liily Company Information

13.4.2 Eli Liily Recombinant Therapeutic Protein Product Offered

13.4.3 Eli Liily Recombinant Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Eli Liily Main Business Overview

13.4.5 Eli Liily Latest Developments

13.5 GlaxoSmithKline

13.5.1 GlaxoSmithKline Company Information

13.5.2 GlaxoSmithKline Recombinant Therapeutic Protein Product Offered

13.5.3 GlaxoSmithKline Recombinant Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GlaxoSmithKline Main Business Overview

13.5.5 GlaxoSmithKline Latest Developments

13.6 Merck

13.6.1 Merck Company Information

13.6.2 Merck Recombinant Therapeutic Protein Product Offered

13.6.3 Merck Recombinant Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Merck Main Business Overview

13.6.5 Merck Latest Developments

13.7 Novartis

13.7.1 Novartis Company Information

13.7.2 Novartis Recombinant Therapeutic Protein Product Offered

13.7.3 Novartis Recombinant Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Novartis Main Business Overview

13.7.5 Novartis Latest Developments

13.8 Regeneron Pharmaceuticals

13.8.1 Regeneron Pharmaceuticals Company Information

13.8.2 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Product Offered

13.8.3 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Regeneron Pharmaceuticals Main Business Overview

13.8.5 Regeneron Pharmaceuticals Latest Developments

13.9 Roche

13.9.1 Roche Company Information

13.9.2 Roche Recombinant Therapeutic Protein Product Offered

13.9.3 Roche Recombinant Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Roche Main Business Overview

13.9.5 Roche Latest Developments

13.10 Takeda

13.10.1 Takeda Company Information

13.10.2 Takeda Recombinant Therapeutic Protein Product Offered

13.10.3 Takeda Recombinant Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Takeda Main Business Overview

13.10.5 Takeda Latest Developments

14 Research Findings and Conclusion

Table 1. Recombinant Therapeutic Protein Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Recombinant Therapeutic Protein Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Recombinant Human Collage

Table 4. Major Players of Recombinant Human Serum Albumin

Table 5. Global Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)

Table 6. Global Recombinant Therapeutic Protein Sales Market Share by Type (2017-2022)

Table 7. Global Recombinant Therapeutic Protein Revenue by Type (2017-2022) & ($ million)

Table 8. Global Recombinant Therapeutic Protein Revenue Market Share by Type (2017-2022)

Table 9. Global Recombinant Therapeutic Protein Sale Price by Type (2017-2022) & (USD/MT)

Table 10. Global Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)

Table 11. Global Recombinant Therapeutic Protein Sales Market Share by Application (2017-2022)

Table 12. Global Recombinant Therapeutic Protein Revenue by Application (2017-2022)

Table 13. Global Recombinant Therapeutic Protein Revenue Market Share by Application (2017-2022)

Table 14. Global Recombinant Therapeutic Protein Sale Price by Application (2017-2022) & (USD/MT)

Table 15. Global Recombinant Therapeutic Protein Sales by Company (2020-2022) & (MT)

Table 16. Global Recombinant Therapeutic Protein Sales Market Share by Company (2020-2022)

Table 17. Global Recombinant Therapeutic Protein Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Recombinant Therapeutic Protein Revenue Market Share by Company (2020-2022)

Table 19. Global Recombinant Therapeutic Protein Sale Price by Company (2020-2022) & (USD/MT)

Table 20. Key Manufacturers Recombinant Therapeutic Protein Producing Area Distribution and Sales Area

Table 21. Players Recombinant Therapeutic Protein Products Offered

Table 22. Recombinant Therapeutic Protein Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Recombinant Therapeutic Protein Sales by Geographic Region (2017-2022) & (MT)

Table 26. Global Recombinant Therapeutic Protein Sales Market Share Geographic Region (2017-2022)

Table 27. Global Recombinant Therapeutic Protein Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Recombinant Therapeutic Protein Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Recombinant Therapeutic Protein Sales by Country/Region (2017-2022) & (MT)

Table 30. Global Recombinant Therapeutic Protein Sales Market Share by Country/Region (2017-2022)

Table 31. Global Recombinant Therapeutic Protein Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Recombinant Therapeutic Protein Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Recombinant Therapeutic Protein Sales by Country (2017-2022) & (MT)

Table 34. Americas Recombinant Therapeutic Protein Sales Market Share by Country (2017-2022)

Table 35. Americas Recombinant Therapeutic Protein Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Recombinant Therapeutic Protein Revenue Market Share by Country (2017-2022)

Table 37. Americas Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)

Table 38. Americas Recombinant Therapeutic Protein Sales Market Share by Type (2017-2022)

Table 39. Americas Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)

Table 40. Americas Recombinant Therapeutic Protein Sales Market Share by Application (2017-2022)

Table 41. APAC Recombinant Therapeutic Protein Sales by Region (2017-2022) & (MT)

Table 42. APAC Recombinant Therapeutic Protein Sales Market Share by Region (2017-2022)

Table 43. APAC Recombinant Therapeutic Protein Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Recombinant Therapeutic Protein Revenue Market Share by Region (2017-2022)

Table 45. APAC Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)

Table 46. APAC Recombinant Therapeutic Protein Sales Market Share by Type (2017-2022)

Table 47. APAC Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)

Table 48. APAC Recombinant Therapeutic Protein Sales Market Share by Application (2017-2022)

Table 49. Europe Recombinant Therapeutic Protein Sales by Country (2017-2022) & (MT)

Table 50. Europe Recombinant Therapeutic Protein Sales Market Share by Country (2017-2022)

Table 51. Europe Recombinant Therapeutic Protein Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Recombinant Therapeutic Protein Revenue Market Share by Country (2017-2022)

Table 53. Europe Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)

Table 54. Europe Recombinant Therapeutic Protein Sales Market Share by Type (2017-2022)

Table 55. Europe Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)

Table 56. Europe Recombinant Therapeutic Protein Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Recombinant Therapeutic Protein Sales by Country (2017-2022) & (MT)

Table 58. Middle East & Africa Recombinant Therapeutic Protein Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Recombinant Therapeutic Protein Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Recombinant Therapeutic Protein Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)

Table 62. Middle East & Africa Recombinant Therapeutic Protein Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)

Table 64. Middle East & Africa Recombinant Therapeutic Protein Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Recombinant Therapeutic Protein

Table 66. Key Market Challenges & Risks of Recombinant Therapeutic Protein

Table 67. Key Industry Trends of Recombinant Therapeutic Protein

Table 68. Recombinant Therapeutic Protein Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Recombinant Therapeutic Protein Distributors List

Table 71. Recombinant Therapeutic Protein Customer List

Table 72. Global Recombinant Therapeutic Protein Sales Forecast by Region (2023-2028) & (MT)

Table 73. Global Recombinant Therapeutic Protein Sales Market Forecast by Region

Table 74. Global Recombinant Therapeutic Protein Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Recombinant Therapeutic Protein Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Recombinant Therapeutic Protein Sales Forecast by Country (2023-2028) & (MT)

Table 77. Americas Recombinant Therapeutic Protein Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Recombinant Therapeutic Protein Sales Forecast by Region (2023-2028) & (MT)

Table 79. APAC Recombinant Therapeutic Protein Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Recombinant Therapeutic Protein Sales Forecast by Country (2023-2028) & (MT)

Table 81. Europe Recombinant Therapeutic Protein Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Recombinant Therapeutic Protein Sales Forecast by Country (2023-2028) & (MT)

Table 83. Middle East & Africa Recombinant Therapeutic Protein Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Recombinant Therapeutic Protein Sales Forecast by Type (2023-2028) & (MT)

Table 85. Global Recombinant Therapeutic Protein Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Recombinant Therapeutic Protein Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Recombinant Therapeutic Protein Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Recombinant Therapeutic Protein Sales Forecast by Application (2023-2028) & (MT)

Table 89. Global Recombinant Therapeutic Protein Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Recombinant Therapeutic Protein Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Recombinant Therapeutic Protein Revenue Market Share Forecast by Application (2023-2028)

Table 92. Boehringer Ingelheim Basic Information, Recombinant Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors

Table 93. Boehringer Ingelheim Recombinant Therapeutic Protein Product Offered

Table 94. Boehringer Ingelheim Recombinant Therapeutic Protein Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 95. Boehringer Ingelheim Main Business

Table 96. Boehringer Ingelheim Latest Developments

Table 97. Bristol-Myers Squibb Basic Information, Recombinant Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors

Table 98. Bristol-Myers Squibb Recombinant Therapeutic Protein Product Offered

Table 99. Bristol-Myers Squibb Recombinant Therapeutic Protein Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 100. Bristol-Myers Squibb Main Business

Table 101. Bristol-Myers Squibb Latest Developments

Table 102. Celldex Therapeutics Basic Information, Recombinant Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors

Table 103. Celldex Therapeutics Recombinant Therapeutic Protein Product Offered

Table 104. Celldex Therapeutics Recombinant Therapeutic Protein Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 105. Celldex Therapeutics Main Business

Table 106. Celldex Therapeutics Latest Developments

Table 107. Eli Liily Basic Information, Recombinant Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors

Table 108. Eli Liily Recombinant Therapeutic Protein Product Offered

Table 109. Eli Liily Recombinant Therapeutic Protein Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 110. Eli Liily Main Business

Table 111. Eli Liily Latest Developments

Table 112. GlaxoSmithKline Basic Information, Recombinant Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors

Table 113. GlaxoSmithKline Recombinant Therapeutic Protein Product Offered

Table 114. GlaxoSmithKline Recombinant Therapeutic Protein Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 115. GlaxoSmithKline Main Business

Table 116. GlaxoSmithKline Latest Developments

Table 117. Merck Basic Information, Recombinant Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors

Table 118. Merck Recombinant Therapeutic Protein Product Offered

Table 119. Merck Recombinant Therapeutic Protein Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 120. Merck Main Business

Table 121. Merck Latest Developments

Table 122. Novartis Basic Information, Recombinant Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors

Table 123. Novartis Recombinant Therapeutic Protein Product Offered

Table 124. Novartis Recombinant Therapeutic Protein Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 125. Novartis Main Business

Table 126. Novartis Latest Developments

Table 127. Regeneron Pharmaceuticals Basic Information, Recombinant Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors

Table 128. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Product Offered

Table 129. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 130. Regeneron Pharmaceuticals Main Business

Table 131. Regeneron Pharmaceuticals Latest Developments

Table 132. Roche Basic Information, Recombinant Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors

Table 133. Roche Recombinant Therapeutic Protein Product Offered

Table 134. Roche Recombinant Therapeutic Protein Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 135. Roche Main Business

Table 136. Roche Latest Developments

Table 137. Takeda Basic Information, Recombinant Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors

Table 138. Takeda Recombinant Therapeutic Protein Product Offered

Table 139. Takeda Recombinant Therapeutic Protein Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 140. Takeda Main Business

Table 141. Takeda Latest Developments

List of Figures

Figure 1. Picture of Recombinant Therapeutic Protein

Figure 2. Recombinant Therapeutic Protein Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Recombinant Therapeutic Protein Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Recombinant Therapeutic Protein Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Recombinant Therapeutic Protein Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Recombinant Human Collage

Figure 10. Product Picture of Recombinant Human Serum Albumin

Figure 11. Global Recombinant Therapeutic Protein Sales Market Share by Type in 2021

Figure 12. Global Recombinant Therapeutic Protein Revenue Market Share by Type (2017-2022)

Figure 13. Recombinant Therapeutic Protein Consumed in Medicine

Figure 14. Global Recombinant Therapeutic Protein Market: Medicine (2017-2022) & (MT)

Figure 15. Recombinant Therapeutic Protein Consumed in Scientific Research

Figure 16. Global Recombinant Therapeutic Protein Market: Scientific Research (2017-2022) & (MT)

Figure 17. Recombinant Therapeutic Protein Consumed in Others

Figure 18. Global Recombinant Therapeutic Protein Market: Others (2017-2022) & (MT)

Figure 19. Global Recombinant Therapeutic Protein Sales Market Share by Application (2017-2022)

Figure 20. Global Recombinant Therapeutic Protein Revenue Market Share by Application in 2021

Figure 21. Recombinant Therapeutic Protein Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Recombinant Therapeutic Protein Revenue Market Share by Company in 2021

Figure 23. Global Recombinant Therapeutic Protein Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Recombinant Therapeutic Protein Revenue Market Share by Geographic Region in 2021

Figure 25. Global Recombinant Therapeutic Protein Sales Market Share by Region (2017-2022)

Figure 26. Global Recombinant Therapeutic Protein Revenue Market Share by Country/Region in 2021

Figure 27. Americas Recombinant Therapeutic Protein Sales 2017-2022 (MT)

Figure 28. Americas Recombinant Therapeutic Protein Revenue 2017-2022 ($ Millions)

Figure 29. APAC Recombinant Therapeutic Protein Sales 2017-2022 (MT)

Figure 30. APAC Recombinant Therapeutic Protein Revenue 2017-2022 ($ Millions)

Figure 31. Europe Recombinant Therapeutic Protein Sales 2017-2022 (MT)

Figure 32. Europe Recombinant Therapeutic Protein Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Recombinant Therapeutic Protein Sales 2017-2022 (MT)

Figure 34. Middle East & Africa Recombinant Therapeutic Protein Revenue 2017-2022 ($ Millions)

Figure 35. Americas Recombinant Therapeutic Protein Sales Market Share by Country in 2021

Figure 36. Americas Recombinant Therapeutic Protein Revenue Market Share by Country in 2021

Figure 37. United States Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Recombinant Therapeutic Protein Sales Market Share by Region in 2021

Figure 42. APAC Recombinant Therapeutic Protein Revenue Market Share by Regions in 2021

Figure 43. China Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Recombinant Therapeutic Protein Sales Market Share by Country in 2021

Figure 50. Europe Recombinant Therapeutic Protein Revenue Market Share by Country in 2021

Figure 51. Germany Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Recombinant Therapeutic Protein Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Recombinant Therapeutic Protein Revenue Market Share by Country in 2021

Figure 58. Egypt Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Recombinant Therapeutic Protein Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Recombinant Therapeutic Protein in 2021

Figure 64. Manufacturing Process Analysis of Recombinant Therapeutic Protein

Figure 65. Industry Chain Structure of Recombinant Therapeutic Protein

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles